Novacyt S.A. (NVYTF)
NVYTF Stock Price Chart
Explore Novacyt S.A. interactive price chart. Choose custom timeframes to analyze NVYTF price movements and trends.
NVYTF Company Profile
Discover essential business fundamentals and corporate details for Novacyt S.A. (NVYTF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Jan 2021
Employees
234.00
Website
https://www.novacyt.comCEO
Lyn Dafydd Rees
Description
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
NVYTF Financial Timeline
Browse a chronological timeline of Novacyt S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Sept 2025
Earnings released on 26 Jun 2025
Earnings released on 30 Apr 2025
Earnings released on 30 Jan 2025
Earnings released on 25 Oct 2024
Earnings released on 25 Jul 2024
Earnings released on 30 May 2024
Earnings released on 31 Dec 2023
EPS came in at -$0.31 , while revenue for the quarter reached $9.12M .
Earnings released on 30 Jun 2023
EPS came in at -$0.07 , while revenue for the quarter reached $2.12M .
Earnings released on 31 Mar 2023
EPS came in at -$0.07 , while revenue for the quarter reached $2.06M .
Earnings released on 31 Dec 2022
EPS came in at -$0.15 , while revenue for the quarter reached $2.76M .
Earnings released on 30 Sept 2022
EPS came in at -$0.14 , while revenue for the quarter reached $2.52M .
Earnings released on 30 Jun 2022
EPS came in at -$0.15 , while revenue for the quarter reached $20.49M , beating expectations by +0.44%.
Earnings released on 31 Dec 2021
EPS came in at $0.05 , while revenue for the quarter reached $46.77M .
Earnings released on 27 Sept 2021
EPS came in at -$0.00 , while revenue for the quarter reached $74.94M , missing expectations by -33.28%.
Earnings released on 30 Jun 2021
EPS came in at -$0.21 , while revenue for the quarter reached $63.25M .
NVYTF Stock Performance
Access detailed NVYTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.